Niclosamide not only blocked the activation of the STAT3/Bcl-2/BCL-xl pathway induced by ionizing radiation in both radiosensitive and radioresistant human lung cancer cells but also overcame acquired radioresistance in vitro and in vivo11. Here, STAT3 is linked to lung carcinoma.